OCEA - Ocean Biomedical, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

OCEA

OCEAN BIOMEDICAL, INC.

OTC

$0.00

▲ UP 0.00% (0.00)

KEY STATISTICS

Market Cap$830.45 K

52w High$0.01

52w Low$0.00

Dividend Yield—

Frequency—

P/E—

Volume7.78K

Shares Out.232.37M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Inderjote Kathuria

ABOUT

SECTOR

Healthcare

WENT PUBLIC

November 8, 2021

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

UPCOMING EARNINGS

DateSep 2, 2026

DayWednesday

Rev. Est.—

SEP

WED

PRICE

$0.00 ▲ UP 0.00% (+$0.00)

About Ocean Biomedical, Inc.

http://www.oceanbiomedical.com ↗

Ocean Biomedical, Inc. is a Providence-based biopharma company developing monoclonal antibodies, small molecules, and vaccines targeting cancer, fibrosis, infectious diseases, and inflammation.

INDUSTRY

Biotechnology

A SERVICE OCEAN BIOMEDICAL, INC. IS KNOWN FOR

Clinical Pipeline of Therapeutic Candidates

Ocean Biomedical develops drugs and vaccines targeting oncology, fibrosis, and infectious diseases, including a malaria vaccine, cancer immunotherapies, and pulmonary fibrosis treatments, currently in various R&D stages.